Spruce Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-33.3M | $-33.3M | $7.0K | $4.6M |
| FY2024 | $-56.0M | $-56.0M | $0 | $5.3M |
| FY2025 | $-33.3M | $-33.3M | — | $2.6M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-33.3M | $-33.3M | $7.0K | $4.6M |
| FY2024 | $-56.0M | $-56.0M | $0 | $5.3M |
| FY2025 | $-33.3M | $-33.3M | — | $2.6M |